Plans4Care: Personalized Dementia Care On-Demand
Plans4Care:按需个性化痴呆症护理
基本信息
- 批准号:10758864
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAgeAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease caregiverAlzheimer&aposs disease related dementiaCaregiver supportCaregiver well-beingCaregiversCaringCellular PhoneClinicalClinical ProtocolsCoinCommunicationComplexComputer softwareComputersDatabasesDaughterDementiaDiseaseEducationEffectivenessElderlyEnrollmentEnvironmentEthnic OriginEvaluationFamilyFamily CaregiverFathersFeedbackFocus GroupsFriendsGeographyHealthcare SystemsHome environmentHospitalizationInterventionLeadLettersLibrariesLinkMapsMarketingMeasuresModificationMonitorNursing HomesPersonal SatisfactionPersonsPhasePrimary CareProviderRaceRandomized, Controlled TrialsRiskSmall Business Innovation Research GrantSortingSpecialistStressSurvey MethodologySymptomsTabletsTechnologyTestingTimeTrainingUnited States National Institutes of Healthaccountable care organizationacute careburnoutcare costscommercializationdashboarddementia caredigital healthcaredigital platformevidence basefamily supporthealth care service utilizationhealthy agingimprovedinterestlearning materialsnovelpersonalized careprimary care practiceprimary care providerprogramsprototyperandomized trialresponsestandardize measuretelephone sessiontoolusability
项目摘要
PROJECT ABSTRACT
Although >11 million family/friends are caregivers to >6 million people with Alzheimer's Disease (AD) and AD-
Related Dementias (AD/ADRD), they do not typically receive personalized education, strategies and support to
manage their own wellbeing and complex dementia-related symptoms. Lack of personalized care contributes
to $321 billion annually in AD/ADRD care costs. In response, our company, Plans4Care, Inc, proposes a Fast-
Track SBIR (PAS-22-196) to build and test a digital platform that delivers personalized care plans to caregivers
on a smartphone, tablet or computer. To generate a personalized care plan, caregivers select a care challenge
(from >50) they seek to address, and respond to brief, easy-to-answer questions (assessment). A novel clinical
algorithm, developed by Plans4Care, maps the challenge and assessment results to the company’s database
of >1,000 evidence-based strategies. A resultant personalized care plan contains education about the care
challenge and specific strategies modifying the environment, communications, tasks, and/or activities.
Caregivers also have access to trained dementia specialists (care advisors) for one-on-one tele-support as
needed. Phase I will develop and evaluate a prototype. Phase I specific aims include: Aim 1: Develop a
clickable prototype with clinical algorithms that map 5 common care challenges to brief assessments and
evidence-based strategies to generate tailored care plans; and Aim 2: Determine feasibility (able to use
platform to identify challenge/generate care plan), acceptability (appeal, appropriateness), and usability (able
to navigate), using focus group and survey methodologies involving validated measures with 25 diverse
caregivers (racially, ethnically, age, relationship, geography). At the conclusion of Phase I, quantitative
milestones (go-no go) to transition to Phase II are: 1) 25 caregivers enrolled; 2) 75% complete assigned
Plans4Care task: onboard, identify care challenge, generate care plan (feasibility); 3) 75% rate Plans4Care
acceptable; and 4) 75% rate navigation easy-to-use (usability). During Phase II, we will ascertain if embedding
Plans4Care into large geriatric primary care practices (part of accountable care organizations) results in
improved caregiver wellbeing and reduced acute care utilization by people with AD/ADRD, and a commercially
viable product. Phase II specific aims include: Aim 3: Incorporate Phase I feasibility feedback to complete
the build out of the platform to address all 50+ care challenges, and develop our solution into a commercial
product; and Aim 4: Conduct a two-group randomized controlled trial (n=160) to evaluate if Plans4Care
improves diverse caregivers’ wellbeing and reduces acute care utilization of people with dementia. This aim
will formally provide evidence for the platform and its implementation in primary care/ACOs. Our company was
competitively selected to participate in the NIA Healthy Aging Start-Up Bootcamp. The commercialization
potential of an easy-to-use tool providing personalized care that is integrated into ACOs is unique and
desperately needed in the marketplace.
项目摘要
尽管> 1100万家人/朋友是> 600万阿尔茨海默氏病(AD)和AD-的护理人员
相关痴呆症(AD/ADRD),他们通常不会获得个性化的教育,策略和支持
管理自己的健康和复杂的痴呆相关符号。缺乏个性化护理有助于
每年3210亿美元的广告/ADRD护理费用。作为回应,我们的公司,Plans4Care,Inc,提议快速
Track Sbir(PAS-22-196)构建和测试一个为照料者提供个性化护理计划的数字平台
在智能手机,平板电脑或计算机上。为了制定个性化护理计划,护理人员选择了护理挑战
(从> 50开始)他们寻求解决并回答简短的,易于提出的问题(评估)。一种新颖的临床
由Plans4Care开发的算法,将挑战和评估结果映射到公司的数据库
> 1,000个基于证据的策略。由此产生的个性化护理计划包含有关护理的教育
挑战和特定策略修改环境,通信,任务和/或活动。
护理人员还可以访问经过培训的痴呆症专家(护理顾问),以进行一对一的电视支持
需要。第一阶段将开发和评估原型。第一阶段的特定目的包括:目标1:开发
可单击的原型具有临床算法,这些算法将5个常见的护理挑战绘制为简短评估和
基于证据的策略来制定量身定制的护理计划;和目标2:确定可行性(能够使用
确定挑战/生成护理计划的平台),可接受性(上诉,适当性)和可用性(能够
导航),使用涉及25位潜水员验证措施的焦点小组和调查方法
照顾者(种族,种族,年龄,关系,地理)。在第一阶段结束时,定量
要过渡到第二阶段的里程碑(Go-no Go)为:1)25名护理人员参加; 2)75%完全分配
计划4CARE任务:机上,确定护理挑战,生成护理计划(可行性); 3)75%的利率计划4Care
可以接受; 4)75%的速率导航易于使用(可用性)。在第二阶段,我们将确定是否嵌入
计划4将大型老年初级保健实践(责任护理组织的一部分)导致
改善了护理人员的福祉,并降低了AD/ADRD的人的急性护理利用和商业上
可行的产品。第二阶段的特定目的包括:目标3:合并I阶段的可行性反馈以完成
平台的建设以应对所有50多种护理挑战,并将我们的解决方案发展为广告
产品;目标4:进行两组随机对照试验(n = 160),以评估是否计划4Care
改善了潜水员护理人员的福祉,并降低了痴呆症患者的急性护理利用。这个目标
将正式提供该平台及其在初级保健/ACO中实施的证据。我们公司是
竞争性地选择参加NIA健康衰老启动训练营。商业化
提供易于使用的工具的潜力,该工具提供了整合到ACO的个性化护理是独一无二的,并且
在市场上迫切需要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Jutkowitz其他文献
Eric Jutkowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Jutkowitz', 18)}}的其他基金
Evaluating the Impact of COVID-19 on Case Management, Health Care Utilization, and Housing Outcomes for HUD-VASH Veterans
评估 COVID-19 对 HUD-VASH 退伍军人的病例管理、医疗保健利用和住房结果的影响
- 批准号:
10641154 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Memory Care in Assisted Living: Does it Improve Quality Outcomes?
辅助生活中的记忆护理:它能提高质量结果吗?
- 批准号:
10807400 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Person-Reported and Health Care Utilization Outcomes of Home and Community Based Care Recipients With and Without Alzheimer's Disease and its Related Dementias
患有和不患有阿尔茨海默病及其相关痴呆症的家庭和社区护理接受者的个人报告和医疗保健利用结果
- 批准号:
10092440 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Did Covid and the Transition to Telehealth Change Person-Reported Outcomes for Home and Community Based Care Recipients With and Without Alzheimer's Disease and its Related Dementias?
新冠疫情和向远程医疗的转变是否改变了患有或不患有阿尔茨海默病及其相关痴呆症的家庭和社区护理接受者的个人报告结果?
- 批准号:
10863580 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia
微观模拟模型比较非药物干预措施管理不同种族/民族痴呆症患者临床症状的有效性和成本效益
- 批准号:
10417166 - 财政年份:2019
- 资助金额:
$ 50万 - 项目类别:
Microsimulation Modeling to Compare the Effectiveness and Cost-Effectiveness of Nondrug Interventions to Manage Clinical Symptoms in Racially/Ethnically Diverse Persons with Dementia
微观模拟模型比较非药物干预措施管理不同种族/民族痴呆症患者临床症状的有效性和成本效益
- 批准号:
10218006 - 财政年份:2019
- 资助金额:
$ 50万 - 项目类别:
Informal Resources of Persons Living with Alzheimer's Disease and Related Dementias: Impact on Hospitalizations, Potentially Avoidable Hopsitalizations and Nursing Home Admissions
阿尔茨海默病和相关痴呆症患者的非正式资源:对住院治疗、可能可以避免的住院治疗和疗养院入院的影响
- 批准号:
9789802 - 财政年份:2018
- 资助金额:
$ 50万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Social-Medical Network: Using a Network Approach to Explore the Integration of Informal and Formal Care Networks of Older Adults
社会医疗网络:利用网络方法探索老年人非正式和正式护理网络的整合
- 批准号:
10724756 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Impacts of Social Determinants of Health and COVID-19 Pandemic Factors on Suicide Risk among Youth
健康社会决定因素和 COVID-19 流行病因素对青少年自杀风险的影响
- 批准号:
10628299 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Integrating the Youth Nominated Support Team (YST) with CBT for Black Youth with Acute Suicide Risk
将青年提名支持团队 (YST) 与针对有急性自杀风险的黑人青年的 CBT 相结合
- 批准号:
10573542 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Building Social and Structural Connections for the Prevention of OUD among Youth Experiencing Homelessness: An RCT Examining Biopsychosocial Mechanisms
建立社会和结构联系以预防无家可归青年中的 OUD:一项检验生物心理社会机制的随机对照试验
- 批准号:
10775030 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别: